Trial Profile
Trial of Rituximab for Graves' Ophthalmopathy
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Graves ophthalmopathy
- Focus Therapeutic Use
- 04 Mar 2015 New trial record